Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs142519821 | chr16:89816745 | G/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs142614596 | chr13:54171029 | C/T | 0.000228 | 177 | 25.77 | 20.17 | 3.17 | KM Plot |
PCPG | rs142660665 | chr2:217040873 | ACT/A | 6.21E-6 | 174 | 25 | 28.87 | 2.93 | KM Plot |
PCPG | rs142663719 | chr10:29842282 | C/T | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs1427339 | chr2:108588292 | A/G | 0 | 177 | 25.27 | 25.53 | 3.17 | KM Plot |
PCPG | rs142820951 | chr2:24322312 | G/A | 0.000122 | 175 | 25.4 | 27.52 | 17.43 | KM Plot |
PCPG | rs142837313 | chr12:56725981 | GA/G | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs142930522 | chr2:118537403 | A/T | 1.67E-5 | 177 | 24.85 | 30.33 | 11.65 | KM Plot |
PCPG | rs143007965 | chr7:105164594 | T/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs143071966 | chr7:105154879 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs143092267 | chr2:24321753 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs143096157 | chr7:158872536 | G/A | 0 | 175 | 25.4 | 41.8 | 3.17 | KM Plot |
PCPG | rs143106090 | chr16:89906800 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs143327743 | chr7:105161012 | T/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs143329043 | chr7:36161644 | C/T | 0.000461 | 176 | 25.87 | 24.23 | 14.37 | KM Plot |